About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland) and was founded in 2006, with the mission to innovate ligand discovery and medicinal target identification.

Philochem has discovered innovative methodologies for biotechnology product development...>>

Recent News

January 3rd, 2013

Philogen S.p.A. announces Worldwide Licensing Agreement with Pfizer Inc. for Dekavil, an Investigational Immunoregulatory Therapy for Autoimmune Diseases.
Please download the
Press Release.

Upcoming Events

Turin, Italy,
10th-12th March 2014

Philochem will be participating in the BIOEurope event in Turin, 10th-12th March 2014.